Will CRISPR Work in Monkeys Confirm Safety for Use in Humans?
Studies using CRISPR on monkeys look encouraging, but more needs to be done before the gene-editing technology can be used on humans.
Studies using CRISPR on monkeys look encouraging, but more needs to be done before the gene-editing technology can be used on humans.
The team who previously stated that CRISPR caused hundreds of unintended mutations are unable to replicate their controversial result.
Scientists have created a new tool that targets not DNA, but RNA, and used it to correct a protein imbalance in cells from a dementia patient, restoring them to healthy levels.
The fragile X syndrome is the most common form of intellectual impairment in men, affecting 1 out of 3,600 boys. Scientists have used CRISPR to restore its activity.
A life sciences expert has warned that obtaining CRISPR IP rights is expected to become a lot more difficult in the near future.
Through genome editing, scientists at Stanford have pinpointed genes that reveal mechanistic details of ALS and may even protect against the degeneration of neurons.
One new gene editing technique is so precise, it’s almost shocking. MhAX, as it’s called, uses CRISPR and a DNA repair system to alter a single DNA base in the human genome.
Even as CRISPR gene-editing technology is offering insights into genetic diseases, researchers are discovering new things about how it actually works. Newly discovered CRISPR mechanism may help prevent dangerous errors.
Improvements to gene-editing techniques hold promise for inactivating the defective gene responsible for Huntington’s Disease.
In a recent interview, Josiah Zayner admitted, “I didn’t realise the consequences of what would happen” after publicly injecting himself with CRISPR.”
Researchers have located a single protein that is able to perform CRISPR-style precise programmable cutting on both DNA and RNA.
Using CRISPR on pigs to create organ regeneration isn’t a new idea, but George Church believes that pig-to-human organ transplant clinical trials could become a reality in just two years.
Technology that’s been used to edit genomes can also spot snippets of DNA. Such detective work may enable rapid, reliable ways to identify infections and cancer.
Gene-editing technology CRISPR is projected to have a fast revenue growth over the next five years, as revenues grow from $779 million in 2017 to $5.2 billion in 2023.
A team from CSHL has published research that indicates the MELK gene is not good target for anti-cancer treatments, contrary to previously held beliefs.